Wall Street split on Anthropic as Tesla, Netflix and Apple draw fresh calls
Two research firms initiated coverage of Anthropic on Friday with opposing ratings, highlighting a divide over whether the artificial-intelligence startup’s growth trajectory justifies its post-IPO valuation. Seaport Research began coverage with a Neutral rating and told clients to “buy later,” citing a sharp deceleration in third-quarter revenue that may not improve in the fourth quarter, CNBC reported.
William Blair started the stock at Outperform, arguing that the risks are “real” but it does not want to “miss the forest for the trees” given Anthropic’s position at the forefront of frontier model development.
The dueling calls arrived alongside a cluster of other rating moves that showed where analyst attention is focused heading into year-end. HSBC upgraded Tesla to Hold from Reduce, saying the strategic logic of a potential merger with SpaceX is “not immediately apparent” and that access to capital might become harder. TD Cowen lifted UnitedHealth to Buy from Hold, pointing to a credible path toward mid-high-teens earnings-per-share growth through 2028.
Bernstein reiterated its Outperform rating on Netflix, stating that double-digit revenue growth in 2027 is achievable though pricing will likely need to do much of the work. UBS kept Apple at Neutral, noting that wait times for the Duo device have fallen about 21 days week-over-week to an average of 53 days across more than 30 geographies, according to its Evidence Lab data.
Anthropic split reflects growth-versus-potential debate

Seaport’s initiation stands out for its explicit caution on the growth curve. The firm said revenue growth “slowed sharply in Q3 and may not improve much in Q4,” adding that to merit its valuation Anthropic will need to see much higher growth rates over the next two years.
“If Anthropic really is the greatest company ever, there will be time to buy later,” the analysts wrote. A Neutral rating typically signals the stock is not obviously broken but lacks a near-term catalyst; firms expecting material downside usually assign Sell or Underperform labels.
William Blair acknowledged the same uncertainty but reached a different conclusion. “In our view, AI is a revolutionary technology, and Anthropic is at the forefront of developing and commercializing AI through its frontier models,” the firm said.
“As with any market in its nascency, there is a lot that is uncertain about the future, including the pace and direction in which it may unfold.” The Outperform rating reflects a willingness to tolerate near-term volatility for exposure to what the firm views as a foundational AI player.
Tesla upgrade tied to SpaceX merger questions
Here are Friday's biggest analyst calls: Anthropic, SpaceX, Tesla, Apple, Netflix, MSG Rangers, United Health & more https://t.co/S5GSyN0z88
HSBC’s move to Hold from Reduce on Tesla was driven by corporate-structure speculation rather than automotive fundamentals. The firm said it does not understand the logic of merging Tesla and SpaceX and assumes control is the motive.
“Strategic logic to merger not immediately apparent; access to capital might be harder,” the analysts wrote. The upgrade acknowledges that a potential transaction changes the equity narrative toward a potential acquisition price, but HSBC stopped short of a Buy rating given the unresolved questions.
UnitedHealth, Netflix and Apple calls round out the day
TD Cowen’s upgrade of UnitedHealth to Buy cited improved visibility into 2027 results, with more than $150 million of EBITDA increasingly looking achievable. The firm sees a credible path to mid-high-teens EPS growth through 2028 and named the stock a top pick for 2027.
Bernstein’s Outperform reiteration on Netflix centered on the durability of its competitive moat. The firm said the debate around long-term moat durability has gotten louder as peers invest more in content, but it believes Netflix can deliver double-digit revenue growth in 2027 with pricing power doing much of the heavy lifting.
UBS held Apple at Neutral while flagging improving supply conditions. Its Evidence Lab tracking showed Duo wait times declining roughly 21 days week-over-week to about 53 days on average across 30-plus geographies, suggesting the initial demand surge is normalizing.
Other notable moves
Oppenheimer raised its Amazon price target to $310 from $285 to reflect the value of Amazon’s ownership stake in Anthropic following the IPO, assuming full conversion of roughly 3.5 billion shares worth about $339 billion at $97 per share, less a 15% holding-company discount. Argus downgraded Berkshire Hathaway to Hold from Buy on valuation grounds, saying the stock trades at 25 times its 2027 operating EPS forecast and is fully valued at current levels.
Macquarie upgraded PDD Holdings to Outperform from Market Perform, citing a prudent marketing strategy and clearer signs of Temu approaching profitability. Guggenheim upgraded Oklo to Buy from Neutral with a $38 price target, encouraged by execution against key milestones across power, isotopes and fuel businesses.
Friday’s confirmed rating actions
Tesla, incorporated in July 2003 by Martin Eberhard and Marc Tarpenning, became the world’s most valuable automaker in July 2020 and has reached a $1 trillion market capitalization three times since October 2021, most recently from May 2025 to July 2026. The company led the battery electric vehicle market with a 17.6% share in 2024 before losing its position as the world’s leading EV manufacturer by the end of 2025.
| Firm | Company | Action | Stated reasoning |
|---|---|---|---|
| Seaport | Anthropic | Initiated Neutral | Revenue growth slowed sharply in Q3; may not improve much in Q4 |
| William Blair | Anthropic | Initiated Outperform | Risks real but don’t want to miss the forest for the trees |
| HSBC | Tesla | Upgraded to Hold from Reduce | Strategic logic of Tesla-SpaceX merger not immediately apparent |
| TD Cowen | UnitedHealth | Upgraded to Buy from Hold | Credible path to mid-high-teens EPS growth through 2028 |
| Bernstein | Netflix | Reiterated Outperform | Double-digit growth possible; pricing to do much of the work in 2027 |
| UBS | Apple | Reiterated Neutral | Duo wait times declined ~21 days WoW to ~53 days average |
The Anthropic divergence captures the broader tension in AI investing: whether to pay up for market leadership amid decelerating growth or wait for a more attractive entry point. Seaport’s “buy later” framing and William Blair’s “forest for the trees” rationale give investors two distinct frameworks for the same newly public company.
Related reading